Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study hypothesis is that new imaging agents \[203Pb\]VMT01 and \[68Ga\]VMT02 can be safely used in humans without independent biological effect and can be used to image melanoma tumors expressing the melanocortin sub-type 1 receptor (MC1R) by SPECT/CT and PET/CT imaging modalities respectively.
Epistemonikos ID: fb4ce9dbc10625fab6305dd0db911415690a35b2
First added on: May 08, 2024